BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Response to oxidative stress
,
Breast Cancer
,
Liver
,
Pharmacogenetics
,
Bleomycin
,
DRD2
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
ec 2
Summary
General Info
Curated Studies
Most Correlated Studies
Embryonal carcinoma NT2/D1-R1 cells treated with low-dose 5-aza-CdR and Dnmt3b knockdown
miRNA expression In maintenance and differentiation of human embryonic stem cells
Breast cancer ER+/- cells with acquired palbociclib resistance
The role of RIP140 in retinoid mediated signaling
Embryonic stem ES-D3 cells treated with embryotoxic and non-toxic monophthalates
Explore Curated Studies Results
Literature
Most Relevant Literature
Identification of Alzheimer's disease-associated rare coding variants in the ECE2 gene.
Endothelin-converting enzymes and related metalloproteases in Alzheimer's disease.
Endothelin-converting enzymes degrade α-synuclein and are reduced in dementia with Lewy bodies.
Dual endothelin-converting enzyme/neutral endopeptidase blockade in rats with D-galactosamine-induce…
Novel therapy approach in primary stroke prevention: simultaneous inhibition of endothelin convertin…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Phase 2 Study Comparing 99mTc-EC-DG SPECT/CT With 18F FDG PET/CT in Patients With Non-small Cell Lun…
A Safety and PK Study of EC-18 in Healthy Subjects
Same Day Oral EC and Implant Initiation
Back to ECE Safely With SAGE: Reducing COVID-19 Transmission in Hispanic and Low-income Preschoolers
A Phase 2 Study of Mirvetuximab Soravtansine (IMGN853) and Pembrolizumab in Endometrial Cancer (EC)
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ